Provided by Tiger Trade Technology Pte. Ltd.

Sensei Biotherapeutics, Inc.

13.85
0.0000
Volume:- -
Turnover:- -
Market Cap:18.56M
PE:-0.10
High:13.85
Open:13.85
Low:13.85
Close:13.85
52wk High:36.76
52wk Low:7.45
Shares:1.34M
Float Shares:810.90K
Volume Ratio:2.41
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-142.7282
EPS(LYR):-16.7239
ROE:-195.26%
ROA:-20.79%
PB:0.11
PE(LYR):-0.83

Loading ...

Sensei Biotherapeutics enters at-the-market equity distribution agreement for up to $150 million stock sale

Reuters
·
Jun 19

Sensei Biotherapeutics director Stephen M. Hahn files initial beneficial ownership statement

Reuters
·
Jun 17

Sensei Biotherapeutics Price Target Maintained With a $55.00/Share by BTIG

Dow Jones
·
Jun 16

Sensei Biotherapeutics changes name to Faeth Therapeutics, adopts ticker FTH

Reuters
·
Jun 15

Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing Piktor, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer

THOMSON REUTERS
·
Jun 15

Sensei Biotherapeutics - Appoints Anand Parikh as Chairman, President and CEO Effective June 12, 2026

THOMSON REUTERS
·
Jun 15

Sensei Biotherapeutics - Piktor Phase 1B/2 Interim Data in Hr+/Her2- Advanced Breast Cancer Expected in 2027

THOMSON REUTERS
·
Jun 15

Sensei Biotherapeutics - Appoints Brian Stephenson as Chief Financial Officer

THOMSON REUTERS
·
Jun 15

Sensei Biotherapeutics - Common Stock to Begin Trading as Fth on Nasdaq on June 16, 2026

THOMSON REUTERS
·
Jun 15

Sensei Biotherapeutics - Piktor Phase 2 Topline Data in Advanced Endometrial Cancer Expected Second Half 2026

THOMSON REUTERS
·
Jun 15

Press Release: Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer

Dow Jones
·
Jun 15

Sensei Biotherapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $55

THOMSON REUTERS
·
Jun 11

Sensei Biotherapeutics initiated with a Buy at BTIG

TIPRANKS
·
Jun 11

Sensei Biotherapeutics Initiated at Buy by BTIG

Dow Jones
·
Jun 11

Sensei Biotherapeutics Overhauls Capital Structure at 2026 Meeting

TIPRANKS
·
Jun 11

Sensei Biotherapeutics shareholders approve increase in authorized common shares to 300,000,000

Reuters
·
Jun 11

Sensei Biotherapeutics grants options for 19,300 shares at $19.79 under 2026 inducement plan

Reuters
·
Jun 05

Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 05

Dual Insider Moves Shake Up Sensei Biotherapeutics Investor Watch

TIPRANKS
·
Jun 02

Sensei Biotherapeutics 10% owner James Peyer sells 25,000 common shares for $500,000

Reuters
·
Jun 02